论文部分内容阅读
目的分析近3年胰岛素在我院的应用及动态,为提高临床治疗依从性、合理性提供参考。方法依据WHO推荐标准并结合临床用药经验,确定胰岛素的限定日剂量(DDD),针对用药频度(DDDs)、金额、日均费用(DDDc)并结合HbA1c等指标进行分析。结果 3年来我院胰岛素DDDs、销售金额逐年递增,胰岛素占降糖西药比例逐年加大,而HbA1c水平逐年递降。短效、预混、中效胰岛素DDDs居前3位,日均费用低于8.5元。超短效、长效胰岛素类似物逐年递增。结论 2008至2010年我院胰岛素的使用渐趋广泛,体现了临床治疗的安全性、有效性、经济性。
Objective To analyze the application and dynamics of insulin in our hospital in recent 3 years and provide references for improving compliance and rationality of clinical treatment. Methods DDD was determined according to WHO recommendation and clinical experience. DDDs, DDDs, HbA1c and other indices were analyzed. Results 3 years of our hospital insulin DDDs, the amount of sales increased year by year, the proportion of insulin accounting for hypoglycemic medicine increased year by year, while the level of HbA1c decreased year by year. Short-acting, premixed, median insulin DDDs top 3, the average daily cost of less than 8.5 yuan. Ultra-short-acting, long-acting insulin analogs increase year by year. Conclusion From 2008 to 2010, the use of insulin in our hospital is becoming more and more widespread, which reflects the safety, effectiveness and economy of clinical treatment.